NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN

被引:558
作者
Wang, Xinjiang
Trotman, Lloyd C.
Koppie, Theresa
Alimonti, Andrea
Chen, Zhenbang
Gao, Zhonghua
Wang, Junru
Erdjument-Bromage, Hediye
Tempst, Paul
Cordon-Cardo, Carlos
Pandolfi, Pier Paolo
Jiang, Xuejun
机构
[1] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Cell Biol Program, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Cenc Biol & Genet Program, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, New York, NY 10021 USA
[4] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA
关键词
D O I
10.1016/j.cell.2006.11.039
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The tumor suppressor PTEN, a critical regulator for multiple cellular processes, is mutated or deleted frequently in various human cancers. Subtle reductions in PTEN expression levels have profound impacts on carcinogenesis. Here we show that PTEN level is regulated by ubiquitin-mediated proteasomal degradation, and purified its ubiquitin ligase as HECT-domain protein NEDD4-1. In cells NEDD4-1 negatively regulates PTEN stability by catalyzing PTEN polyubiquitination. Consistent with the tumor-suppressive role of PTEN, overexpression of NEDD4-1 potentiated cellular transformation. Strikingly, in a mouse cancer model and multiple human cancer samples where the genetic background of PTEN was normal but its protein levels were low, NEDD4-1 was highly expressed, suggesting that aberrant upregulation of NEDD4-1 can posttranslationally suppress PTEN in cancers. Elimination of NEDD4-1 expression inhibited xenotransplanted tumor growth in a PTENdependent manner. Therefore, NEDD4-1 is a potential proto-oncogene that negatively regulates PTEN via ubiquitination, a paradigm analogous to that of Mdm2 and p53.
引用
收藏
页码:129 / 139
页数:11
相关论文
共 42 条
  • [11] Bioconductor: open software development for computational biology and bioinformatics
    Gentleman, RC
    Carey, VJ
    Bates, DM
    Bolstad, B
    Dettling, M
    Dudoit, S
    Ellis, B
    Gautier, L
    Ge, YC
    Gentry, J
    Hornik, K
    Hothorn, T
    Huber, W
    Iacus, S
    Irizarry, R
    Leisch, F
    Li, C
    Maechler, M
    Rossini, AJ
    Sawitzki, G
    Smith, C
    Smyth, G
    Tierney, L
    Yang, JYH
    Zhang, JH
    [J]. GENOME BIOLOGY, 2004, 5 (10)
  • [12] Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN
    Gray, IC
    Stewart, LMD
    Phillips, SMA
    Hamilton, JA
    Gray, NE
    Watson, GJ
    Spurr, NK
    Snary, D
    [J]. BRITISH JOURNAL OF CANCER, 1998, 78 (10) : 1296 - 1300
  • [13] The ubiquitin system
    Hershko, A
    Ciechanover, A
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1998, 67 : 425 - 479
  • [14] The Nedd4 family of E3 ubiquitin ligases: functional diversity within a common modular architecture
    Ingham, RJ
    Gish, G
    Pawson, T
    [J]. ONCOGENE, 2004, 23 (11) : 1972 - 1984
  • [15] Exploration, normalization, and summaries of high density oligonucleotide array probe level data
    Irizarry, RA
    Hobbs, B
    Collin, F
    Beazer-Barclay, YD
    Antonellis, KJ
    Scherf, U
    Speed, TP
    [J]. BIOSTATISTICS, 2003, 4 (02) : 249 - 264
  • [16] TUMOR SPECTRUM ANALYSIS IN P53-MUTANT MICE
    JACKS, T
    REMINGTON, L
    WILLIAMS, BO
    SCHMITT, EM
    HALACHMI, S
    BRONSON, RT
    WEINBERG, RA
    [J]. CURRENT BIOLOGY, 1994, 4 (01) : 1 - 7
  • [17] Distinct characteristics of two human Nedd4 proteins with respect to epithelial Na+ channel regulation
    Kamynina, E
    Tauxe, C
    Staub, O
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2001, 281 (03) : F469 - F477
  • [18] DJ-1, a novel regulator of the tumor suppressor PTEN
    Kim, RH
    Peters, M
    Jang, YJ
    Shi, W
    Pintilie, M
    Fletcher, GC
    DeLuca, C
    Liepa, J
    Zhou, L
    Snow, B
    Binari, RC
    Manoukian, AS
    Bray, MR
    Liu, FF
    Tsao, MS
    Mak, TW
    [J]. CANCER CELL, 2005, 7 (03) : 263 - 273
  • [19] Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression
    Kwabi-Addo, B
    Giri, D
    Schmidt, K
    Podsypanina, K
    Parsons, R
    Greenberg, N
    Ittmann, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (20) : 11563 - 11568
  • [20] PTEN function: how normal cells control it and tumour cells lose it
    Leslie, NR
    Downes, CP
    [J]. BIOCHEMICAL JOURNAL, 2004, 382 : 1 - 11